Results 21 to 30 of about 100,501 (300)
A Case of Multifactorial Viral Myocarditis [PDF]
, 2021 We present a case of viral myocarditis in the setting of Coxsackievirus and coronavirus disease 2019 (COVID-19) infection. This case is unique as there were two underlying active infections that could have caused the patient's myocarditis.
Tagliaferri, Ariana R +6 more
core +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 Numerous studies have demonstrated that gut microbiota plays an important role in the development and treatment of different cardiovascular diseases, including hypertension, heart failure, myocardial infarction, arrhythmia, and atherosclerosis ...
Jingyue Wang +17 more
doaj +1 more source
The Lancet, 2012 Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease ...
Sandeep, Sagar +2 more
openaire +2 more sources
Frontiers in Immunology, 2022 Background and ObjectiveImmune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems.
Xiaohong Xie +16 more
doaj +1 more source
COVID myocarditis: a review of the literature
Monaldi Archives for Chest Disease, 2023 Myocarditis is a potentially fatal complication of coronavirus disease 2019 (COVID‐19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. COVID‐19 myocarditis appears to have distinct inflammatory characteristics
Angelica Cersosimo +4 more
doaj +1 more source
Circulation Research, 2016 Viral myocarditis remains a prominent infectious-inflammatory disease for patients throughout the lifespan. The condition presents several challenges including varied modes of clinical presentation, a range of timepoints when patients come to attention, a diversity of approaches to diagnosis, a spectrum of clinical courses, and unsettled perspectives ...
Gabriel, Fung +4 more
openaire +2 more sources
Cardiovascular Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Case Reports. [PDF]
Cancer Rep (Hoboken)ABSTRACT Background Reports of immune checkpoint inhibitor (ICI) therapy‐associated immune‐related adverse events (irAEs) exhibit considerable heterogeneity, particularly when comparing data from clinical trials and real‐world observational studies. Methods We conducted a systematic review of real‐world observational studies (case reports and series ...
Godin SL +4 more
europepmc +2 more sources
Electrocardiographic features of immune checkpoint inhibitor-associated myocarditis. [PDF]
, 2022 Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myocarditis, whilst improving cancer-related outcomes.
Song, Wenhua +10 more
core +1 more source
COVID-19 and myocarditis: a review of literature
The Egyptian Heart Journal, 2022 Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.
Mohammed Ali +8 more
doaj +1 more source
Inflammatory cardiomyopathy - diagnosis and risk stratification in myocarditis [PDF]
, 2020 Background: Acute myocarditis remains a challenging clinical diagnosis with limited epidemiological data and poorly defined markers of adverse risk. We sought to build a better understanding of myocarditis epidemiology and to integrate clinical, genetic
Lota, Amrit S.
core +1 more source